Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2010 2
2011 4
2012 2
2013 1
2014 3
2015 2
2016 2
2017 8
2018 5
2019 3
2020 4
Text availability
Article attribute
Article type
Publication date

Search Results

33 results
Results by year
Filters applied: . Clear all
Page 1
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Faissner S, Plemel JR, Gold R, Yong VW. Faissner S, et al. Among authors: plemel jr. Nat Rev Drug Discov. 2019 Dec;18(12):905-922. doi: 10.1038/s41573-019-0035-2. Epub 2019 Aug 9. Nat Rev Drug Discov. 2019. PMID: 31399729 Review.
Cell transplantation therapy for spinal cord injury.
Assinck P, Duncan GJ, Hilton BJ, Plemel JR, Tetzlaff W. Assinck P, et al. Among authors: plemel jr. Nat Neurosci. 2017 Apr 25;20(5):637-647. doi: 10.1038/nn.4541. Nat Neurosci. 2017. PMID: 28440805 Review.
Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy.
Plemel JR, Michaels NJ, Weishaupt N, Caprariello AV, Keough MB, Rogers JA, Yukseloglu A, Lim J, Patel VV, Rawji KS, Jensen SK, Teo W, Heyne B, Whitehead SN, Stys PK, Yong VW. Plemel JR, et al. Glia. 2018 Feb;66(2):327-347. doi: 10.1002/glia.23245. Epub 2017 Oct 25. Glia. 2018. PMID: 29068088
Remyelination therapies: a new direction and challenge in multiple sclerosis.
Plemel JR, Liu WQ, Yong VW. Plemel JR, et al. Nat Rev Drug Discov. 2017 Sep;16(9):617-634. doi: 10.1038/nrd.2017.115. Epub 2017 Jul 7. Nat Rev Drug Discov. 2017. PMID: 28685761 Review.
Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells.
Baaklini CS, Rawji KS, Duncan GJ, Ho MFS, Plemel JR. Baaklini CS, et al. Among authors: plemel jr. Front Mol Neurosci. 2019 Sep 19;12:225. doi: 10.3389/fnmol.2019.00225. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31616249 Free PMC article.
The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.
Duncan GJ, Manesh SB, Hilton BJ, Assinck P, Plemel JR, Tetzlaff W. Duncan GJ, et al. Among authors: plemel jr. Glia. 2020 Feb;68(2):227-245. doi: 10.1002/glia.23706. Epub 2019 Aug 21. Glia. 2020. PMID: 31433109 Review.
Biochemically altered myelin triggers autoimmune demyelination.
Caprariello AV, Rogers JA, Morgan ML, Hoghooghi V, Plemel JR, Koebel A, Tsutsui S, Dunn JF, Kotra LP, Ousman SS, Wee Yong V, Stys PK. Caprariello AV, et al. Among authors: plemel jr. Proc Natl Acad Sci U S A. 2018 May 22;115(21):5528-5533. doi: 10.1073/pnas.1721115115. Epub 2018 May 4. Proc Natl Acad Sci U S A. 2018. PMID: 29728463 Free PMC article.
Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ, Plemel JR, Assinck P, Manesh SB, Muir FGW, Hirata R, Berson M, Liu J, Wegner M, Emery B, Moore GRW, Tetzlaff W. Duncan GJ, et al. Among authors: plemel jr. Acta Neuropathol. 2017 Sep;134(3):403-422. doi: 10.1007/s00401-017-1741-7. Epub 2017 Jun 19. Acta Neuropathol. 2017. PMID: 28631093
Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system.
Micu I, Plemel JR, Caprariello AV, Nave KA, Stys PK. Micu I, et al. Among authors: plemel jr. Nat Rev Neurosci. 2018 Jan;19(1):49-58. doi: 10.1038/nrn.2017.128. Epub 2017 Nov 9. Nat Rev Neurosci. 2018. PMID: 29118449 Review.
Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.
Plemel JR, Juzwik CA, Benson CA, Monks M, Harris C, Ploughman M. Plemel JR, et al. Mult Scler. 2015 Oct;21(12):1485-95. doi: 10.1177/1352458515601513. Epub 2015 Aug 18. Mult Scler. 2015. PMID: 26286700 Review.
33 results
Jump to page